We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nuformix Plc | LSE:NFX | London | Ordinary Share | GB00BYW79Y38 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -5.41% | 0.175 | 0.17 | 0.18 | - | 1,097,760 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -859k | -0.0012 | -1.50 | 1.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2017 17:40 | Just correcting a simpleton. | soupdragon55 | |
19/12/2017 17:10 | I think you're trying to split hairs and add a few words. '£2.5 mill up front cash deal' Your version: 'up front full payment' Ffs. Got nothing better to do ? | simpletonremover | |
19/12/2017 16:38 | Not saying it's not an achievement, but it's not an up front full payment as you posted. | soupdragon55 | |
19/12/2017 16:33 | It's still £2.5 mill cash in a major licencing deal in China plus a 10% royalty stream. Next, they're licencing the rest of the world with it. That's an achievement when you consider the number of pharmaceutical stocks that haven't received a penny after years of development. It's only one of six products they've got patented. Low risk because it works by improving drugs already tested and in use. The next product they're looking to announce on is even more transformational. Listen to the podcast. | simpletonremover | |
19/12/2017 16:05 | £2.5m aggregate cash deal, aggregate being a key word. It's not the full £2.5 up front. | soupdragon55 | |
19/12/2017 14:30 | Makes no difference which PI is ramping or not. The stock doesn't need it, it's doing fine on it's own. £2.5 mill up front cash deal and a healthy royalty deal going forward in China. Plenty more in the pipeline too. | simpletonremover | |
19/12/2017 13:46 | Aberdeenman, he of the infamous CTAG ramp & collapse (amongst others) ("CTAG should still come good"sic) is ramping the very balls off this on twitter. 10p, 20p, 30p soon! | bbmsionlypostafter | |
19/12/2017 13:36 | Rathean - it's a reaction to the Voxmarkets podcast by CeO | croasdalelfc | |
19/12/2017 13:25 | VAL fully priced imo, over bought so watch for a big correction before sense prevails. Big buying here today, someone building a position... | rathean | |
18/12/2017 09:40 | Great RNS at VAL. Market not woken up to the huge potential there. | cudmore | |
17/12/2017 21:50 | This could be another one to watch this week but I think all eyes will be on LION again. | cudmore | |
17/12/2017 19:57 | Simpleton.... very apt name considering! I'm actually invested in nfx you donut!, & it's clear to see if you re-read my post again that I'm not de-ramping a company that I'm invested in. All I was saying is I expect to see a bit of consolidation before moving on to new highs. As you should know... we need to back test our highs before moving on again. I'm sure you would, along with me see the share price on a gradual trend upwards over the next couple of weeks/months/years, rather than sharp increase, followed by sharp declines, as the overused phase goes, nothing goes up in straight lines! Next time you might be less sensitive on trying to pull up a fellow investor in the same company! Not be the can't take any criticism crew, only that everything is amazing & this is going to £1 by the end of the week, boom, to the moon, rockets & fireworks crew! | natty27 | |
17/12/2017 09:48 | There's no hype on this at all. Hardly any posts on here. There's a lot more hype on MORE by you, looking at your posts, which is just a cash shell. NFX have secured significant cash and a double digit royalty deal in China with more in the pipeline. Try deramping a stock that isn't performing, it'll be much easier for you. | simpletonremover | |
17/12/2017 08:56 | Could see maybe a slight pull back for consolidation before moving on, a lot of hype on this share, everyone getting caught up in the pyc rise & has high expectations. Not saying this then couldn't move on to new highs after this period imo. | natty27 | |
17/12/2017 08:23 | Beauforts actually have a 10p target. | soupdragon55 | |
16/12/2017 19:51 | 15p targethTTps://www.be | croasdalelfc | |
15/12/2017 14:01 | heading in the right direction | falia | |
15/12/2017 07:37 | Nice RNS. Got a few here though not many | gersemi | |
17/10/2017 09:07 | Guess this price is a bargain then... :D | babbler | |
16/10/2017 12:46 | Presumably long term holders of LVRT are taking the opportunity of making decent gains of c. 200 percent on the re listing by trading today so true value of the new company difficult to discern at this time. Directors' buys at 4 p a share tends to show their expectations as regarding current worth which I am content to accept. As always dyor | maytrees | |
16/10/2017 12:38 | !FOLLOWFEED Having held LVRT when share trading was suspended in September 2016 I had wondered if the mooted RTO with NFX would proceed. Confirmation of the RTO being accompanied by full details of Nuformix's drugs development program give grounds for optimism hence I continue to hold ftb though dyor | maytrees |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions